Biodexa Pharmaceuticals (BDRX) Non-Current Debt (2013 - 2024)
Biodexa Pharmaceuticals (BDRX) posted Non-Current Debt of $151,453 for the quarter ended Dec 31, 2024, down 58.6% from $366,140 a year earlier.
Powered by 
Analysis
Biodexa Pharmaceuticals (BDRX) Non-Current Debt (2013 - 2024) Analysis & Trends
As of Dec 31, 2024, Biodexa Pharmaceuticals' Non-Current Debt came in at $150,836, down 58.9% from the prior year.
- Annual Non-Current Debt has declined for three consecutive years, with a five-year compound annual growth rate of -53.9% (years ended Dec 2019 to Dec 2024).
- In prior years, Biodexa Pharmaceuticals' Non-Current Debt was $366,928 in the year ended Dec 31, 2023 (-36.0%), $573,013 in the year ended Dec 31, 2022 (-32.8%), $853,045 in the year ended Dec 31, 2021 and $77,049 in the year ended Dec 31, 2020 (-98.9%).
- The figure for the quarter ended Dec 31, 2024 stands as the lowest quarterly Non-Current Debt since the quarter ended Dec 31, 2020.
- The strongest year-over-year quarter for Non-Current Debt in the past five years was the quarter ended Dec 31, 2021, with growth of 954.9%; the weakest was the quarter ended Dec 31, 2020, with a decline of 98.9%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 37.34 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 62.48 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 51.08 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | -108.00 Mn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 51.86 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 23.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 60.50 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | - |
| 10 | Biodexa Pharmaceuticals | 41.06 Mn | 17.85 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 151,453.22 |
| Jun 30, 2024 | 262,541.92 |
| Dec 31, 2023 | 366,139.81 |
| Jun 30, 2023 | 475,518.00 |
| Dec 31, 2022 | 543,065.81 |
| Jun 30, 2022 | 687,585.56 |
| Dec 31, 2021 | 835,766.58 |
| Jun 30, 2021 | 953,250.67 |
| Dec 31, 2020 | 79,227.06 |
| Jun 30, 2020 | 132,861.43 |
| Dec 31, 2019 | 7.29 Mn |
| Jun 30, 2019 | 492,657.73 |
| Dec 31, 2018 | 1.14 Mn |
| Jun 30, 2018 | 8.39 Mn |
| Dec 31, 2017 | 8.21 Mn |
| Jun 30, 2017 | 1.56 Mn |
| Dec 31, 2016 | 2.01 Mn |
| Jun 30, 2016 | 2.07 Mn |
| Dec 31, 2015 | 2.29 Mn |
| Dec 31, 2014 | 2.36 Mn |
API Access
Biodexa Pharmaceuticals Non-Current Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-debt&ticker=BDRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-debt", "ticker": "BDRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-debt&ticker=BDRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();